Logo image of IPI

INTREPID POTASH INC (IPI) Stock Fundamental Analysis

NYSE:IPI - New York Stock Exchange, Inc. - US46121Y2019 - Common Stock - Currency: USD

25.49  -0.88 (-3.34%)

After market: 25.4 -0.09 (-0.35%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IPI. IPI was compared to 85 industry peers in the Chemicals industry. While IPI has a great health rating, there are worries on its profitability. IPI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IPI had negative earnings in the past year.
In the past year IPI had a positive cash flow from operations.
In multiple years IPI reported negative net income over the last 5 years.
Each year in the past 5 years IPI had a positive operating cash flow.
IPI Yearly Net Income VS EBIT VS OCF VS FCFIPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

IPI's Return On Assets of -5.34% is on the low side compared to the rest of the industry. IPI is outperformed by 78.31% of its industry peers.
The Return On Equity of IPI (-6.33%) is worse than 69.88% of its industry peers.
Industry RankSector Rank
ROA -5.34%
ROE -6.33%
ROIC N/A
ROA(3y)12.34%
ROA(5y)6.89%
ROE(3y)14.18%
ROE(5y)7.81%
ROIC(3y)N/A
ROIC(5y)N/A
IPI Yearly ROA, ROE, ROICIPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100

1.3 Margins

IPI's Operating Margin has declined in the last couple of years.
IPI has a Gross Margin of 10.33%. This is amonst the worse of the industry: IPI underperforms 84.34% of its industry peers.
IPI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for IPI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.33%
OM growth 3YN/A
OM growth 5Y-64.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y35.3%
GM growth 5Y-6.41%
IPI Yearly Profit, Operating, Gross MarginsIPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

7

2. Health

2.1 Basic Checks

IPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
IPI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IPI has less shares outstanding
IPI has a worse debt/assets ratio than last year.
IPI Yearly Shares OutstandingIPI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
IPI Yearly Total Debt VS Total AssetsIPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

IPI has an Altman-Z score of 2.22. This is not the best score and indicates that IPI is in the grey zone with still only limited risk for bankruptcy at the moment.
IPI has a Altman-Z score of 2.22. This is comparable to the rest of the industry: IPI outperforms 59.04% of its industry peers.
IPI has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
The Debt to FCF ratio of IPI (0.07) is better than 98.80% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that IPI is not too dependend on debt financing.
IPI has a better Debt to Equity ratio (0.00) than 96.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 2.22
ROIC/WACCN/A
WACC9.08%
IPI Yearly LT Debt VS Equity VS FCFIPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

IPI has a Current Ratio of 4.41. This indicates that IPI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.41, IPI belongs to the top of the industry, outperforming 92.77% of the companies in the same industry.
A Quick Ratio of 1.87 indicates that IPI should not have too much problems paying its short term obligations.
IPI has a better Quick ratio (1.87) than 71.08% of its industry peers.
Industry RankSector Rank
Current Ratio 4.41
Quick Ratio 1.87
IPI Yearly Current Assets VS Current LiabilitesIPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

IPI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -175.00%.
IPI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.60%.
IPI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.03% yearly.
EPS 1Y (TTM)-175%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.58%
Revenue 1Y (TTM)-11.6%
Revenue growth 3Y12.31%
Revenue growth 5Y6.03%
Sales Q2Q%5.66%

3.2 Future

The Earnings Per Share is expected to decrease by -15.38% on average over the next years. This is quite bad
The Revenue is expected to decrease by -3.01% on average over the next years.
EPS Next Y28.46%
EPS Next 2Y-16.95%
EPS Next 3Y-15.38%
EPS Next 5YN/A
Revenue Next Year-13.38%
Revenue Next 2Y-5.41%
Revenue Next 3Y-3.01%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IPI Yearly Revenue VS EstimatesIPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
IPI Yearly EPS VS EstimatesIPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 5 -5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IPI. In the last year negative earnings were reported.
Also next year IPI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPI Price Earnings VS Forward Price EarningsIPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

IPI's Enterprise Value to EBITDA is on the same level as the industry average.
IPI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IPI is cheaper than 80.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.03
EV/EBITDA 10.41
IPI Per share dataIPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

A cheap valuation may be justified as IPI's earnings are expected to decrease with -15.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.95%
EPS Next 3Y-15.38%

More info and screens

0

5. Dividend

5.1 Amount

IPI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTREPID POTASH INC

NYSE:IPI (2/21/2025, 8:04:00 PM)

After market: 25.4 -0.09 (-0.35%)

25.49

-0.88 (-3.34%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)03-10 2025-03-10/amc
Inst Owners61.52%
Inst Owner Change5.31%
Ins Owners1.29%
Ins Owner Change-3.82%
Market Cap335.45M
Analysts42.22
Price Target19.38 (-23.97%)
Short Float %2.66%
Short Ratio2.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-647.37%
Min EPS beat(2)-1288.12%
Max EPS beat(2)-6.63%
EPS beat(4)0
Avg EPS beat(4)-351.28%
Min EPS beat(4)-1288.12%
Max EPS beat(4)-6.63%
EPS beat(8)0
Avg EPS beat(8)-231.5%
EPS beat(12)1
Avg EPS beat(12)-161.47%
EPS beat(16)4
Avg EPS beat(16)-113.17%
Revenue beat(2)2
Avg Revenue beat(2)24.77%
Min Revenue beat(2)20.59%
Max Revenue beat(2)28.94%
Revenue beat(4)4
Avg Revenue beat(4)25.45%
Min Revenue beat(4)20.59%
Max Revenue beat(4)28.94%
Revenue beat(8)8
Avg Revenue beat(8)26.87%
Revenue beat(12)11
Avg Revenue beat(12)19.53%
Revenue beat(16)15
Avg Revenue beat(16)18.75%
PT rev (1m)0%
PT rev (3m)5.56%
EPS NQ rev (1m)18.18%
EPS NQ rev (3m)-212.5%
EPS NY rev (1m)26.09%
EPS NY rev (3m)29.17%
Revenue NQ rev (1m)-5.78%
Revenue NQ rev (3m)-5.78%
Revenue NY rev (1m)-0.7%
Revenue NY rev (3m)-0.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.31
P/FCF 11.03
P/OCF 4.82
P/B 0.49
P/tB 0.51
EV/EBITDA 10.41
EPS(TTM)-0.75
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)2.31
FCFY9.07%
OCF(TTM)5.29
OCFY20.74%
SpS19.42
BVpS51.72
TBVpS49.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.34%
ROE -6.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.33%
FCFM 11.9%
ROA(3y)12.34%
ROA(5y)6.89%
ROE(3y)14.18%
ROE(5y)7.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.04%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-64.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y35.3%
GM growth 5Y-6.41%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA 0.07
Cap/Depr 102.8%
Cap/Sales 15.32%
Interest Coverage N/A
Cash Conversion 235.77%
Profit Quality N/A
Current Ratio 4.41
Quick Ratio 1.87
Altman-Z 2.22
F-Score4
WACC9.08%
ROIC/WACCN/A
Cap/Depr(3y)138.85%
Cap/Depr(5y)139.45%
Cap/Sales(3y)17%
Cap/Sales(5y)19.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-175%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.58%
EPS Next Y28.46%
EPS Next 2Y-16.95%
EPS Next 3Y-15.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.6%
Revenue growth 3Y12.31%
Revenue growth 5Y6.03%
Sales Q2Q%5.66%
Revenue Next Year-13.38%
Revenue Next 2Y-5.41%
Revenue Next 3Y-3.01%
Revenue Next 5YN/A
EBIT growth 1Y-151.33%
EBIT growth 3YN/A
EBIT growth 5Y-62.85%
EBIT Next Year6149.13%
EBIT Next 3Y292.1%
EBIT Next 5YN/A
FCF growth 1Y-31.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.66%
OCF growth 3Y11.6%
OCF growth 5Y-7.61%